Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Fredrik G. Oberg"'
Publikováno v:
Cancer Research. 83:2691-2691
Background: Fostroxacitabine bralpamide (fostrox) is an orally administered liver-targeted troxacitabine-based nucleotide prodrug currently undergoing phase 1/2a clinical trial in advanced hepatocellular carcinoma (HCC), in combination with pembroliz